Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Pediatr Crit Care Med. 2021 Oct 1;22(10):e513–e523. doi: 10.1097/PCC.0000000000002729

Table 2.

Clinical outcomes during the pre-intervention and post-intervention period

Data expressed as median (Q1, Q3) or n (%).

Variable Pre-intervention group (N=190) Post-intervention group (N=144)
Hospital LOS (days) 25 (12, 45.7) 20 (10, 34)
PICU LOS (days) 9 (4, 16) 8 (4, 16)
VFD28 (days) 23.3 (15.9, 25.5) 23.2 (16.5, 26)
Lorazepam usage (n) 41 (21.5) 65 (45.1)
Lorazepam (mg/kg/ICU day) 0 (0, 0) 0 (0, 0.019)
Adverse events
Unplanned extubation 8 (4.2) 2 (1.4)
Failed extubation 11 (5.8) 7 (4.9)
Cardiorespiratory arrest event 6 (3.2) 3 (2.1)
24-hour readmission 7 (3.7) 1 (0.7)
Total 32 (16.8) 13 (9.0)

LOS = length of stay, VFD28 = ventilator-free days up to 28 days.